FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

  • Kevin Chung

Press/Media

Period8 Apr 2025

Media coverage

1

Media coverage

  • TitleFDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery
    Media name/outletCardiac Vascular News
    Country/TerritoryUnited States
    Date8/04/25
    URLct.moreover.com/?a=56446870867&p=1gw&v=1&x=Qd6ebzb5qoJYCiugP2mjaQ
    PersonsKevin Chung
View all 1
View less